CD8A and neoplasm: Adoptive therapy with ALDHA1 peptide specific CD8+T cells resulted in the inhibition of tumor growth and metastasis, as well as a prolonged survival rate of the xenograft-bearing immunodeficient mice, according to Visus et al. [24].